Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Samoa Tech Journal.
Press releases published on August 21, 2025

サイ・ライフ・サイエンシズ (Sai Life Sciences)、短期的な気候目標に対するSBTiの認定を取得
インド・ハイデラバード発, Aug. 21, 2025 (GLOBE NEWSWIRE) -- イノベーターに焦点を当てた受託研究、開発…

Bilibili Inc. Announces Second Quarter 2025 Financial Results
SHANGHAI, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the …

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at …
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for …

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical, non-clinical …

DataParser Announces Support for RingCentral: Expanding Horizons in Enterprise Communication Compliance
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 17a-4’s DataParser, a trusted name in enterprise data integration and compliance solutions, is proud to announce the latest expansion of its platform: support for RingCentral, a global leader in cloud-based …

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President …

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
Achieving the primary endpoint in both Denali and the first NCX 470 Phase 3 trial, Mont Blanc, meets efficacy requirements for approval in the U.S. and China NCX 470 was also superior to latanoprost in the reduction of intraocular pressure (IOP) from …

Nicox annonce des résultats positifs pour NCX 470 dans l’étude de Phase 3 Denali chez des patients atteints de glaucome
21 août 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule …

Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering price of $0.52 per share and, to certain …

KINDERCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against KinderCare Learning Companies, Inc. - KLC
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2025 to file lead plaintiff applications in a securities class action lawsuit against KinderCare Learning …

NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against Neogen …

SELECTQUOTE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against SelectQuote, Inc. - SLQT
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. …

SABLE OFFSHORE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Sable Offshore Corp. - SOC
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 26, 2025 to file lead plaintiff applications in a securities class action lawsuit against Sable Offshore …

FLYWIRE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Flywire Corporation - FLYW
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against Flywire …

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims …

Invoice finance fintech FundTap transforms eSigning processes with Annature
BRISBANE, Australia, Aug. 20, 2025 (GLOBE NEWSWIRE) -- FundTap, a fast-growing fintech platform delivering on-demand invoice finance to small businesses across Australia and New Zealand, has transformed its eSigning experience through a strategic …

Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use
SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 …

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated …